| scholarly article | Q13442814 |
| P2093 | author name string | von Eckardstein A | |
| Assmann G | |||
| Schulte H | |||
| Funke H | |||
| P921 | main subject | triglyceride | Q186319 |
| risk factor | Q1475848 | ||
| P304 | page(s) | M8-14 | |
| P577 | publication date | 1998-10-01 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | The emergence of triglycerides as a significant independent risk factor in coronary artery disease | |
| P478 | volume | 19 Suppl M |
| Q44486605 | A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn Study |
| Q35585570 | APOE polymorphisms contribute to reduced atorvastatin response in Chilean Amerindian subjects |
| Q37226724 | Amino acid supplementation decreases plasma and liver triacylglycerols in elderly. |
| Q34062910 | Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population |
| Q35549437 | Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study |
| Q90745468 | Bezafibrate Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Hypertriglyceridemic Patients with Type 2 Diabetes Mellitus |
| Q37680512 | C771G (His241Gln) polymorphism of MLXIPL gene, TG levels and coronary artery disease: a case control study. |
| Q24815489 | Centile values for serum lipids and blood pressure for Asian Indian adolescents |
| Q34107183 | Common mutations of the lipoprotein lipase gene and their clinical significance |
| Q37435512 | Comparison of Mustard Oil and Ghee Consumption on the History of Coronary Heart Disease in Urban Population of India |
| Q33802196 | Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia. |
| Q33715404 | Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy. |
| Q33993678 | Current, new and future treatments in dyslipidaemia and atherosclerosis |
| Q45155924 | Dyslipidemia in patients with angiographically confirmed coronary artery disease--an opportunity for improvement |
| Q36013120 | Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels. |
| Q35215347 | Effects of age, sex, and menopausal status on blood cholesterol profile in the korean population |
| Q85893683 | Effects of combined treatment with simvastatin and L-carnitine on triglyceride levels in diabetic patients with hyperlipidaemia |
| Q44285920 | Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia. |
| Q35048009 | Fenofibrate-induced hyperhomocysteinaemia: clinical implications and management |
| Q24203618 | Fibrates for primary prevention of cardiovascular disease events |
| Q28214326 | Goals of statin therapy: three viewpoints |
| Q34962244 | Hypertriglyceridemia and risk of coronary heart disease |
| Q36789642 | Lipid Profile of Anti-Retroviral Treatment-Naïve HIV-Infected Patients in Jos, Nigeria |
| Q30491799 | Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial. |
| Q36449143 | Management strategies of dyslipidemia in the elderly: 2005. |
| Q44412315 | New features of the national cholesterol education program adult treatment panel III lipid-lowering guidelines |
| Q34423344 | Nontraditional serum lipid variables and recurrent stroke risk |
| Q34107425 | Postprandial lipemia and coronary risk |
| Q25255110 | Potential roles of ROR-alpha in cardiovascular endocrinology |
| Q33808302 | Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study |
| Q37258789 | Prevalence of metabolic syndrome in turkmen ethnic groups in gorgan |
| Q37336667 | Psychological insulin resistance: patient beliefs and implications for diabetes management |
| Q55266064 | Relations of lipid parameters, other variables with carotid intima-media thickness and plaque in the general Chinese adults: an observational study. |
| Q37574603 | Richard Havel, Howard Eder, and the evolution of lipoprotein analysis |
| Q55715533 | Screening Cardiovascular Risk in Patients with High Depression Scores. |
| Q37784203 | The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications. |
| Q35602242 | The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial |
| Q34564466 | The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution |
| Q37418399 | The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins |
| Q39556962 | Treatment targets in the management of dyslipidemias: which targets in whom? |
| Q47373716 | Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014. |
| Q33654016 | Triglycerides and Cardiovascular Risk |
| Q34027254 | Triglycerides and coronary risk |
| Q34703867 | Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters |
| Q34406987 | Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides |
Search more.